MannKind (MNKD) Reaches $2.54 After 9.00% Down Move; Golub Capital Bdc (GBDC) Shorts Decreased By 21.44%

January 11, 2018 - By Nellie Frank

The stock of MannKind Corporation (NASDAQ:MNKD) is a huge mover today! The stock decreased 1.54% or $0.0398 during the last trading session, reaching $2.5402. About 976,734 shares traded. MannKind Corporation (NASDAQ:MNKD) has declined 75.27% since January 11, 2017 and is downtrending. It has underperformed by 91.97% the S&P500.The move comes after 8 months negative chart setup for the $301.96M company. It was reported on Jan, 11 by Barchart.com. We have $2.31 PT which if reached, will make NASDAQ:MNKD worth $27.18M less.

Golub Capital Bdc Incorporated (NASDAQ:GBDC) had a decrease of 21.44% in short interest. GBDC’s SI was 296,800 shares in January as released by FINRA. Its down 21.44% from 377,800 shares previously. With 141,500 avg volume, 2 days are for Golub Capital Bdc Incorporated (NASDAQ:GBDC)’s short sellers to cover GBDC’s short positions. The stock increased 0.22% or $0.04 during the last trading session, reaching $17.95. About 69,275 shares traded. Golub Capital BDC, Inc. (NASDAQ:GBDC) has risen 21.93% since January 11, 2017 and is uptrending. It has outperformed by 5.23% the S&P500.

Among 7 analysts covering Mannkind (NASDAQ:MNKD), 2 have Buy rating, 3 Sell and 2 Hold. Therefore 29% are positive. Mannkind had 15 analyst reports since August 3, 2015 according to SRatingsIntel. RBC Capital Markets maintained MannKind Corporation (NASDAQ:MNKD) on Tuesday, May 10 with “Underperform” rating. As per Friday, August 28, the company rating was downgraded by Vetr. As per Wednesday, January 6, the company rating was maintained by Piper Jaffray. H.C. Wainwright maintained MannKind Corporation (NASDAQ:MNKD) on Wednesday, November 8 with “Buy” rating. The rating was downgraded by Griffin Securities on Monday, November 16 to “Neutral”. The firm has “Underperform” rating given on Wednesday, January 6 by RBC Capital Markets. Maxim Group maintained the stock with “Buy” rating in Friday, September 1 report. The rating was maintained by Maxim Group on Friday, August 11 with “Buy”. The stock of MannKind Corporation (NASDAQ:MNKD) earned “Underperform” rating by RBC Capital Markets on Wednesday, November 4. The firm has “Buy” rating by H.C. Wainwright given on Tuesday, October 24.

Analysts await MannKind Corporation (NASDAQ:MNKD) to report earnings on March, 15. They expect $-0.29 earnings per share, down 52.63% or $0.10 from last year’s $-0.19 per share. After $-0.31 actual earnings per share reported by MannKind Corporation for the previous quarter, Wall Street now forecasts -6.45% EPS growth.

MannKind Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic products for diabetes diseases in the United States. The company has market cap of $301.96 million. The Company’s approved product is Afrezza, a rapid-acting, inhaled insulin used to control high blood sugar in adults with type 1 and type 2 diabetes. It currently has negative earnings.

Among 5 analysts covering Golub Capital BDC (NASDAQ:GBDC), 2 have Buy rating, 0 Sell and 3 Hold. Therefore 40% are positive. Golub Capital BDC had 9 analyst reports since August 24, 2015 according to SRatingsIntel. The stock of Golub Capital BDC, Inc. (NASDAQ:GBDC) has “Neutral” rating given on Tuesday, September 20 by Janney Capital. As per Sunday, July 23, the company rating was maintained by Keefe Bruyette & Woods. The stock has “Neutral” rating by National Securities on Thursday, November 3. The firm has “Buy” rating by Cantor Fitzgerald given on Tuesday, September 1. The stock of Golub Capital BDC, Inc. (NASDAQ:GBDC) earned “Market Perform” rating by Keefe Bruyette & Woods on Friday, May 13. As per Monday, August 24, the company rating was upgraded by Wells Fargo. On Monday, March 27 the stock rating was upgraded by Raymond James to “Outperform”. The firm has “Mkt Perform” rating by Raymond James given on Friday, February 10. The rating was maintained by Keefe Bruyette & Woods on Thursday, October 5 with “Hold”.

Investors sentiment decreased to 1.4 in Q3 2017. Its down 0.35, from 1.75 in 2017Q2. It dived, as 8 investors sold Golub Capital BDC, Inc. shares while 35 reduced holdings. 18 funds opened positions while 42 raised stakes. 22.10 million shares or 2.55% less from 22.68 million shares in 2017Q2 were reported. Blackrock Incorporated stated it has 0% in Golub Capital BDC, Inc. (NASDAQ:GBDC). Ares Management Ltd Liability Co holds 0.16% of its portfolio in Golub Capital BDC, Inc. (NASDAQ:GBDC) for 254,429 shares. Invesco Ltd accumulated 0% or 147,792 shares. Novare Capital Management Lc reported 29,950 shares stake. Williams Jones Assocs Limited Liability Co owns 37,000 shares. Evercore Wealth Management Ltd Com owns 18,272 shares for 0.01% of their portfolio. Segment Wealth Management Ltd Liability Corp stated it has 0.08% in Golub Capital BDC, Inc. (NASDAQ:GBDC). M&T Bancshares invested in 0% or 22,202 shares. Pinebridge Invests L P has invested 0.01% in Golub Capital BDC, Inc. (NASDAQ:GBDC). Crawford Inv Counsel holds 0.04% or 63,195 shares in its portfolio. Glenmede Tru Na stated it has 0% in Golub Capital BDC, Inc. (NASDAQ:GBDC). Bancshares Of Mellon has invested 0.01% in Golub Capital BDC, Inc. (NASDAQ:GBDC). Goldman Sachs Group has invested 0% in Golub Capital BDC, Inc. (NASDAQ:GBDC). Atlantic Tru Group Inc Ltd Liability Corp invested in 0.01% or 138,334 shares. Nationwide Fund Advisors has invested 0% in Golub Capital BDC, Inc. (NASDAQ:GBDC).

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.